Jamie Clark74
Regular
278 messages
joined Sep 2004
New PE treatment clears first hurdle
A new medication designed to delay premature ejaculation, developed by
Johnson & Johnson, has successfully passed its initial testing phase. According to
The Wall Street Journal, the results from this large-scale study were presented at the annual meeting of the
American Urological Association (AUA) in San Antonio. The data suggests that
dapoxetine could be a game-changer for men looking to delay ejaculation. Historically, doctors have had to rely on existing medications—often antidepressants—to manage this. However, since those aren't "official" treatments for this specific issue, manufacturers aren't allowed to market them for that purpose.
Data from the AUA indicates that premature ejaculation is actually the most common sexual dysfunction among men. "It’s an incredibly widespread issue affecting anywhere from 10 to 30 percent of men. For the first time, we actually have something that works," noted Dr. Jon Pryor, head of urological surgery at the University of Minnesota. This new drug is effective when taken one to three hours before intercourse; participants using dapoxetine saw their time significantly increase, jumping from less than a minute to over three minutes after penetration. For context, the typical range is usually between 7 and 9 minutes.
posted at 08:03;
May 25, 2005
P.S. Anyone on antidepressants knows firsthand how those meds can lead to impotence or other sexual side effects.
comment: what acts as poison for one can be medicine for another!
😎
